Gregory L Willis Selected Research

N- (2- (1- naphthalenyl)ethyl)cyclobutanecarboxamide

11/2004

Recovery of experimental Parkinson's disease with the melatonin analogues ML-23 and S-20928 in a chronic, bilateral 6-OHDA model: a new mechanism involving antagonism of the melatonin receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gregory L Willis Research Topics

Disease

13	Parkinson Disease (Parkinson's Disease) 02/2018 - 01/2004
3	Tremor (Tremors) 01/2018 - 01/2005
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2008 - 01/2007
1	Sleep Wake Disorders 01/2018
1	Nervous System Diseases (Neurological Disorders) 03/2012
1	Weight Loss (Weight Reduction) 11/2008
1	Seborrheic Dermatitis 01/2008
1	Body Weight (Weight, Body) 01/2008
1	Hypotension (Low Blood Pressure) 01/2008
1	Hyperplasia 01/2008
1	MPTP Poisoning 01/2005
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2005
1	Psychotic Disorders (Schizoaffective Disorder) 01/2004
1	Dyskinesias (Dyskinesia) 01/2004

Drug/Important Bio-Agent (IBA)

9	Dopamine (Intropin)FDA LinkGeneric 01/2018 - 01/2004
5	MelatoninIBA 01/2008 - 11/2004
3	Therapeutic UsesIBA 01/2014 - 09/2005
3	ML 23IBA 09/2005 - 11/2004
2	Oxidopamine (6 Hydroxydopamine)IBA 11/2008 - 11/2004
1	BenzodiazepinesIBA 01/2008
1	Levodopa (L Dopa)FDA LinkGeneric 01/2008
1	Antidepressive Agents (Antidepressants)IBA 01/2007
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2005
1	N- (2- (1- naphthalenyl)ethyl)cyclobutanecarboxamideIBA 11/2004
1	Melatonin Receptors (Melatonin Receptor)IBA 11/2004

Therapy/Procedure

4	Phototherapy (Light Therapy) 02/2018 - 01/2007
3	Therapeutics 03/2012 - 01/2004
1	Pinealectomy 11/2004